Skip to content

Cytokinetics CYTK Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$129.84M+76.2%$122.52M+29.2%$225.47M+381%$74.94M-60.6%$73.68M-38.6%
$688.71M-20.3%$759.7M-22.6%$737.07M-23.6%$783.2M-9.6%$864.54M+73.3%
$6.83M+239%$17.76M+6.7%$1.81M+641%$8.41M$2.01M+141%
$839.47M-12.2%$916.98M-17.2%$977.35M-4.0%$886.54M-17.0%$956.05M+49.7%
$82.44M+22.7%$79.19M+20.3%$76M+18.3%$70.22M+6.9%$67.18M-1.2%
$1.27B+0.7%$1.42B+1.6%$1.44B0.0%$1.23B-19.6%$1.26B+56.4%
$24.71M+77.2%$22.34M+9.7%$22.08M+90.7%$16.23M+71.4%$13.94M+7.5%
$1.65M$1.61M$1.61M
$44.81M+246%$41.18M+257%$17.28M+50.0%$14.4M$12.96M
$199.19M+24.7%$202.45M+12.7%$142.14M+29.4%$131.06M+27.5%$159.73M+79.8%
$247.21M+169%$246.38M+164%$158.75M+70.7%$159.06M+71.3%$92.03M+62.0%
$2.1B+37.2%$2.08B+35.6%$1.96B+35.0%$1.59B+12.7%$1.53B+27.1%
$124K+4.2%$123K+4.2%$122K+3.4%$119K+1.7%$119K+13.3%
-$3.69B-29.0%-$3.49B-29.1%-$3.3B-29.5%-$3B-25.4%-$2.86B-27.4%
-$826.57M-210%-$659.63M-387%-$521.12M-3,646%-$368.72M-440%-$266.41M+32.8%
$1.27B+0.7%$1.42B+1.6%$1.44B0.0%$1.23B-19.6%$1.26B+56.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Cytokinetics's total assets?
Cytokinetics (CYTK) holds $1.3B in total assets, up 0.8% year over year.
How much debt does Cytokinetics have?
Cytokinetics carries $418.2M in total debt against -$826.6M of shareholders' equity, a debt-to-equity ratio of 2.21.
How much cash does Cytokinetics have?
Cytokinetics holds $129.8M in cash and equivalents.
Can Cytokinetics cover its short-term obligations?
Its current ratio is 4.21 — current assets exceed current liabilities.
Where does Cytokinetics's balance sheet data come from?
Every line is extracted from Cytokinetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.